OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
OKUR
49 hedge funds and large institutions have $25.8M invested in OnKure Therapeutics, Inc. Class A Common Stock in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+2
Holders Change %
+4.26%
% of All Funds
0.66%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
16
Reduced
13
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ACA
Acorn Capital Advisors
New York
|
+$3.35M |
| 2 |
SC
Shay Capital
New York
|
+$1.51M |
| 3 |
CF
Cantor Fitzgerald
New York
|
+$1.29M |
| 4 |
BlackRock
New York
|
+$1.14M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$537K |
Top Sellers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$7.9M |
| 2 |
PA
Perceptive Advisors
New York
|
-$4.32M |
| 3 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$3.54M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.09M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$821K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PA
51
Perceptive Advisors
New York
| – | -$4.32M | -1,004,439 | Closed |
|
|
SB
52
Samsara BioCapital
Palo Alto,
California
| – | -$3.54M | -824,155 | Closed |
|
|
IC
53
Ikarian Capital
Dallas,
Texas
| – | -$1.09M | -253,754 | Closed |
|
|
BFM
54
Boothbay Fund Management
New York
| – | -$335K | -78,021 | Closed |
|
55
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$80.3K | -18,663 | Closed |
|